CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer.
about
Identification of T-cadherin as a novel target of DNA methyltransferase 3B and its role in the suppression of nerve growth factor-mediated neurite outgrowth in PC12 cellsBRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cellsQuantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors.Intra- and interindividual epigenetic variation in human germ cells.Distinguishing Lung Adenocarcinoma from Lung Squamous Cell Carcinoma by Two Hypomethylated and Three Hypermethylated Genes: A Meta-Analysis.Gene-gene interaction analysis identifies a new genetic risk factor for colorectal cancer.Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer.HPV16 integration probably contributes to cervical oncogenesis through interrupting tumor suppressor genes and inducing chromosome instability.Revealing the Strong Functional Association of adipor2 and cdh13 with adipoq: A Gene Network Study.Role of CDH13 promoter methylation in the carcinogenesis, progression, and prognosis of colorectal cancer: A systematic meta-analysis under PRISMA guidelines.Adiponectin and Intelectin-1: Important Adipokine Players in Obesity-Related Colorectal CarcinogenesisAberrant Methylation of T-cadherin Can Be a Diagnostic Biomarker for Colorectal Cancer.Clinical significance of CDH13 promoter methylation in serum samples from patients with bladder transitional cell carcinoma.Downregulation of Mus81 as a novel prognostic biomarker for patients with colorectal carcinoma.Loss of T-cadherin (CDH-13) regulates AKT signaling and desensitizes cells to apoptosis in melanoma.MS-MLPA reveals progressive age-dependent promoter methylation of tumor suppressor genes and possible role of IGSF4 gene in colorectal carcinogenesis of microsatellite instable tumors.
P2860
Q28580458-405B388D-E43C-4D9D-BF0D-A29FA4AAA785Q28586417-B1FEC6C1-667F-4B0F-AD52-CADCEE0FD016Q34573834-104EC8AC-D707-41AD-A46A-E78E3BCD6BA9Q34658413-91897F95-6EBE-40EF-82BD-DE86D15D21C3Q35919451-025060F5-54E6-4E38-BED3-AB2EC66136CAQ36050189-DB1CDB92-E00E-4CE3-91AB-665FE58E852BQ36615378-C76F8D78-F587-4BD1-A3AE-6809A64C69D4Q37440587-9F9C9E72-9875-4AA6-8DDE-5E1AC7A9A8B2Q38470599-60DFC373-8159-44A8-AB24-6ADD22EB74DEQ38765935-0C25C4A7-66FC-4DA0-903E-558D5C3E5C28Q39250237-EE1816B8-787F-4C39-AFC5-F57BA92ECE9EQ41525873-20949B62-C519-456F-888E-143DE1233FE1Q44045391-B10B7E75-D768-4C1A-8EC4-6BB4A14234D4Q50550953-6CC751A4-DDE4-48C3-BCA0-08DE6CA1666AQ51033999-14B0E93B-5B54-4D85-A717-E695E3BAA785Q54451205-CACFA793-8F4A-4BCB-B812-A8389CC04D74
P2860
CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
CDH13 promoter region is speci ...... ferentiated colorectal cancer.
@ast
CDH13 promoter region is speci ...... ferentiated colorectal cancer.
@en
type
label
CDH13 promoter region is speci ...... ferentiated colorectal cancer.
@ast
CDH13 promoter region is speci ...... ferentiated colorectal cancer.
@en
prefLabel
CDH13 promoter region is speci ...... ferentiated colorectal cancer.
@ast
CDH13 promoter region is speci ...... ferentiated colorectal cancer.
@en
P2093
P2860
P356
P1476
CDH13 promoter region is speci ...... ferentiated colorectal cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601647
P407
P577
2004-03-01T00:00:00Z